Laurion Capital Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-20,671
Closed -$1.9M – 707
2021
Q4
$1.9M Buy
20,671
+14,905
+258% +$1.78M 0.02% 286
2021
Q3
$731K Hold
5,766
– – ﹤0.01% 537
2021
Q2
$959K Buy
+5,766
New +$934K 0.01% 448
2020
Q3
– Sell
-9,728
Closed -$1.86M – 1142
2020
Q2
$1.86M Buy
+9,728
New +$1.7M 0.02% 333
2017
Q4
– Sell
-7,300
Closed -$242K – 1830
2017
Q3
$242K Buy
+7,300
New +$239K ﹤0.01% 1389

Other funds holding TDOC

Laurion Capital Management's TDOC Position: Q1 2022 in Review

Laurion Capital Management sold out of Teladoc Health (TDOC) in Q1 2022, closing a stake of 20,671 shares — an estimated $1.9M sold.

Laurion Capital Management first reported a position in TDOC in Q3 2017 and held it in 5 quarters. The position peaked at $1.9M in Q4 2021. 680 funds tracked by Wall St. Rank hold TDOC as of Q1 2022.

  • Laurion Capital Management reported no remaining Teladoc Health position as of Q1 2022 after selling out during the quarter.
  • Laurion Capital Management sold 20,671 Teladoc Health shares in Q1 2022, an estimated $1.9M.
  • Laurion Capital Management first reported a position in Teladoc Health in Q3 2017 and held it in 5 quarters.
  • Laurion Capital Management's Teladoc Health position peaked at $1.9M in Q4 2021.
  • 680 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2022.

Based on Laurion Capital Management's 13F filing for Q1 2022, filed 16 May 2022.